HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

10th Edition of International Conference on Neurology and Brain Disorders

October 21-23, 2024

October 21 -23, 2024 | Baltimore, Maryland, USA

INBC 2018

Speaker at Neuroscience Conference - Stephen Grossberg
Keynote Presentation (In-Person)
Stephen Grossberg, Boston University, United States

This talk will describe brain mechanisms of learning, memory, and cognition and how they may break down during mental disorders such as Alzheimer’s disease, medial temporal amnesia, autism, and visual and auditory neglect. These processes are described by Adaptive Resonance [....] » Read More

Speaker at Neuroscience Conference - Ken Ware
Keynote Presentation (In-Person)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

In 2013 world renowned Paralympian John Maclean became the first long term paraplegic to walk again. Maclean had been 25 years wheelchair dependent pre engaging in NeuroPhysics Therapy (NPT) and within the first 3 days of this controversial therapy Maclean took his first recorded [....] » Read More

Speaker at Neurology Conferences - Maria-Magdalena Georgescu
Keynote Presentation (In-Person)
Maria-Magdalena Georgescu, Louisiana State University, United States

Glioblastoma is a deadly brain tumor with a median survival of 1.3 years after surgery, radiotherapy and chemotherapy.  The dismal prognosis is due to the propensity of the tumor to invade adjacent normal brain. Although next generation sequencing led to genomic landscaping [....] » Read More

Speaker at Brain Disorders Conference - Corina O. Bondi
Keynote Presentation (In-Person)
Corina O. Bondi, University of Pittsburgh, United States

Traumatic brain injuries (TBI) impact millions of Americans, with older patients being more likely to have a co-occurring condition, particularly dementia. Galantamine (GAL), a first-line drug used to treat dementia, acts primarily as an acetylcholinesterase inhibitor and has bee [....] » Read More

Speaker at Brain Disorders Conference - Harry W.M. Steinbusch
Oral Presentation (In-Person)
Harry W.M. Steinbusch, Maastricht University, Netherlands

Despite the fundamental role of the brainstem in regulating vital functional abilities such as arousal, breathing, autonomic nervous system activity as well as regulating all higher cerebral functions via neurotransmitter projections systems originating in the brainstem, the role [....] » Read More

Speaker at Neurology Conferences - Floyd Thompson
Oral Presentation (In-Person)
Floyd Thompson, Brain Rehabilation Center, North Florida/South Gergia Veterans Health Systems, United States

Spasticity is a major health problem for patients with moderate to severe TBI. Progressive development of spasticity following TBI often represents a significant barrier for practical re-entry of TBI patients into the community. This preclinical study evaluated the safety and eff [....] » Read More

Speaker at Neuroscience Conference - Luca Malfassi
Oral Presentation (In-Person)
Luca Malfassi, La Cittadina Fondazione Studi e Ricerche Veterinarie, Romanengo, Italy and Azienda Socio Sanitaria Territoriale di Lodi, Italy

We evaluated stereotactic volume modulated arc radiotherapy (VMAT RT) for canine gliomas, alone (RT) and in combination with temozolomide (RT+TMZ), compared to palliation. Overall and disease-specific survival times were estimated. Thirty dogs were palliated, 22 dogs were treated [....] » Read More

Speaker at Brain Disorders Conference - Karol S. Bruzik
Oral Presentation (In-Person)
Karol S. Bruzik, The University of Illinois at Chicago, United States

Heteropentameric GABA-A receptor is a principal drug target whose function is allosterically modulated by general anesthetics, sedatives and anticonvulsants, such as propofol, etomidate, barbiturates and neurosteroids. The current clinically used general anesthetics have numerous [....] » Read More

Speaker at Neurology Conferences - Swetlana Sirko
Oral Presentation (In-Person)
Swetlana Sirko, Ludwig-Maximilians-University Munich, Germany

Astrocytes have a critical role in ensuring optimal brain functions,from supporting neuronal metabolism and survival to maintenance of blood?brain barrier. However, it took along time to recognize the central role of astrocytes in response to diverse types of CNS damage, such as [....] » Read More

Speaker at Neuroscience Conference - Vittorio Maglione
Oral Presentation (In-Person)
Vittorio Maglione, IRCCS Neuromed, Italy

Huntington's disease (HD), the most common dominantly inherited neurodegenerative disorder is characterized by a progressive striatal and cortical neurodegeneration associated with cognitive and behavioral disturbance. The disease-causing mutation is an polyglutamine (polyQ) [....] » Read More

Speaker at Brain Disorders Conference - Valida Isanova
Oral Presentation (In-Person)
Valida Isanova, Kazan State Medical University, Russian Federation

The nervous system disorders and mental impairments still remain to be among the main causes of children and adults incapacity. Currently neurorehabilitation has a particular relevance and importance among people suffering from nervous system disorders, incapable of moving i [....] » Read More

Speaker at Neurology Conferences - Jodie Marquez
Oral Presentation (In-Person)
Jodie Marquez, University of Newcastle, Australia

Background: Technological advances have led to the emergence of robotic exoskeletons as a potential therapy option for patients with neurological conditions. To date, the body of evidence has focused on the spinal cord injury population but more recently there has been growi [....] » Read More

Speaker at Neuroscience Conference - Anthony E. Kline
Oral Presentation (In-Person)
Anthony E. Kline, University of Pittsburgh, United States

Traumatic brain injury (TBI) affects two million people in the United States each year and several million more worldwide, making it a significant health care issue. Brain traumas range from mild to severe with the former being the case in most occurrences and generally not displ [....] » Read More

Speaker at Brain Disorders Conference - P. Hemachandra Reddy
Keynote Presentation (In-Person)
P. Hemachandra Reddy, Texas Tech University Health Sciences, United States

Synaptic pathology and mitochondrial oxidative damage are early events in AD progression. Loss of synapses and synaptic damage are the best correlates of cognitive deficits found in AD patients. Recent research on Aβ, tau mitochondria and synapses in AD revealed that Aβ [....] » Read More

Speaker at Neurology Conferences - Ichiro Maruyama
Keynote Presentation (In-Person)
Ichiro Maruyama, Okinawa Institute of Science and Technology Graduate University, Japan

Glioblastoma multiforme (GBM) is a common form of adult primary brain tumor, and diffusely and aggressively invade both hemispheres of the brain. Patients prognosis is dismal with median survival times ranging from12 to 15 months after diagnosis. In primary GBMs, the epidermal gr [....] » Read More

Speaker at Brain Disorders Conference - Svyatoslav Medvedev
Keynote Presentation (In-Person)
Svyatoslav Medvedev, Institute of the Human Brain RAS, Russian Federation

Currently, the so-called activation studies are the dominant approach to investigate the functional organization of the brain. Within the framework of these studies, the functional specialization of certain brain structures with respect to the types of activity under investigatio [....] » Read More

Speaker at Neuroscience Conference - Margarit Tadevosyan
Keynote Presentation (In-Person)
Margarit Tadevosyan, Artmed Medical Rehabilitation Center, Armenia

Today combat-related mental disorders related to the extraordinary stress are the most commonly reported mental health disorders among medical and sociological problems. The actuality of these disorders is determined by polygenic and multifact?rial essence of combat trauma (the i [....] » Read More

Speaker at Neuroscience Conference - Ken Ware
Oral Presentation (In-Person)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

In 2013 world renowned Paralympian John Maclean became the first long term paraplegic to walk again. Maclean had been 25 years wheelchair dependent pre engaging in NeuroPhysics Therapy (NPT) and within the first 3 days of this controversial therapy Maclean took his first recorded [....] » Read More

Speaker at Neurology Conferences - Nicola Postol
Oral Presentation (In-Person)
Nicola Postol, University of Newcastle, Australia

Background: Access to high intensity weight-bearing exercise for those with severe mobility impairment post stroke is very limited. Technological advancements have led to the development of a variety of overground lower limb robotic exoskeletons. Only the REX Bionics Exoskel [....] » Read More

Speaker at Neuroscience Conference - Eleonora Palmieri
Oral Presentation (In-Person)
Eleonora Palmieri, University in Macerata, Italy

Executive Disorders. Functional analysis, habilitative treatments and early prevention. Today neurobiological and pedagogic convergences allow the development of  knowledge of Executive Functions  (E.F. ) and their  contributions to   the activati [....] » Read More

Speaker at Brain Disorders Conference - Yasutoshi Koga
Oral Presentation (In-Person)
Yasutoshi Koga, Kurume University Graduate School of Medicine, Japan

Among pediatricians and neurologists who treat patients with MELAS, there is an urgent need for clinical evidence on the effective treatment for them. To date, pharmacotherapy with L-arginine has been suggested to be promising for patients with MELAS. We conducted 9-year clinical [....] » Read More

Speaker at Neurology Conferences - Eugenia V Gurevich
Oral Presentation (In-Person)
Eugenia V Gurevich, Vanderbilt University, United States

Arrestins were first discovered as the key proteins responsible for the shutoff of the G protein-dependent signaling by G protein-coupled receptors. Later arrestins were found to regulate multiple signaling pathways, including mitogen activated protein (MAP) kinase pathways, by s [....] » Read More

Speaker at Neuroscience Conference - Arun L. Jayaraman
Oral Presentation (In-Person)
Arun L. Jayaraman, Mayo Clinic Arizona, United States

Delirium is a frequently preventable complication associated with significant morbidity and mortality. Post-operative delirium occurs in up to half of all elderly patients undergoing anesthesia and surgery. Not only does this result in increased hospital length of stay and cost, [....] » Read More

Speaker at Brain Disorders Conference - CarolAnn Peterson
Oral Presentation (Virtual)
CarolAnn Peterson, University of Southern California, United States

The workshop is designed to inform researchers, doctors, faculty, advocates and others who may interact/encounter victims of domestic violence, strangulation and/or traumatic brain injury; along with the ability to ask the appropriate questions of all 3 types of clients/patients. [....] » Read More

Speaker at Brain Disorders Conference - Richard Francis
Poster Presentation (In-Person)
Richard Francis, Royal united hospital, United Kingdom

Takayasu Arteritis is a large vessel vasculitis more commonly affecting the aorta and its direct branches (Silver 2012). Cerebral aneurysms are uncommon; but associated with Takayasu's and are routinely found in areas of increased haemodynamic stress with a significant predil [....] » Read More

Speaker at Neuroscience Conference - Baranowska-Bosiacka Irena
Poster Presentation (In-Person)
Baranowska-Bosiacka Irena, Pomeranian Medical University in Szczecin, Poland

Lead (Pb) is an environmental neurotoxin which particularly affects the developing brain but the molecular mechanism of its neurotoxicity is not fully understood. The aim of our study was to examine whether pre- and neonatal exposure to Pb (concentration of Pb in rat offspring bl [....] » Read More

Speaker at Neurology Conferences - Marta Goschorsk
Poster Presentation (In-Person)
Marta Goschorsk, Pomeranian Medical University in Szczecin, Poland

Pathogenesis of neurodegenerative diseases  (i.e. Alzheimer's disease)  is supposed to be associated with neuroinflammation involving the activation of i.e. macrophages. Macrophages are a diverse group of cells which includes microglia in the central nervous system. [....] » Read More

Speaker at Brain Disorders Conference - Izabela Gutowska
Poster Presentation (In-Person)
Izabela Gutowska, Pomeranian Medical University in Szczecin, Poland

Fluorine is a strong neurotoxin which causes the degeneration of structures such as hippocampus, prefrontal cortex, and cerebellum. Fluorine exposure inhibits the activity of brain receptors and decreases the production of neurotransmitters. Exposure to fluorine in childhood can [....] » Read More

Speaker at Neurology Conferences - Hiroko Ikeshima Kataoka
Poster Presentation (In-Person)
Hiroko Ikeshima Kataoka, Kieo University, Japan

Brain is not easy to cure when it has damage or inflammation occurs, because neurons are never regenerate after the degeneration. We have been focusing on one of the glial cells, astrocytes which has the important role in the central nervous system to transfer some of the nutriti [....] » Read More

Speaker at Neuroscience Conference - Hyun Im Moon
Poster Presentation (In-Person)
Hyun Im Moon, Bundang Jesaeng Hospital, Korea, Republic of

Introduction: Visual perception (VP) is a process that involves ‘visual acceptance’ and ‘visual cognition’ through interaction between multiple areas in the human brain. About 35-75% of patients with brain damage have particular impairments in VP that infl [....] » Read More

Speaker at Brain Disorders Conference - Kruchinina Margarita Vitalievna
Poster Presentation (In-Person)
Kruchinina Margarita Vitalievna, Research Institute of internal and Preventive Medicine- Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Russian Federation

The aim of the work was to assess the red blood cell (RBC) role as a participant in vasoregulation in the patients with ischemic stroke (IS) from two points: first, as a direct deliverer of NO and a stimulator of NO-release via RBC generated ATP. Materials and methods.&nb [....] » Read More

Speaker at Neurology Conferences - Wasik Agnieszka
Poster Presentation (In-Person)
Wasik Agnieszka, Institute of Pharmacology PAS, Poland

Background: Human population living in urban environment is exposed to excessive levels of toxins, such as fluorine (F). Fluorine present in excess, e.g. in water or soil have a strong impact on living organisms. Passing through the blood-brain barrier, it damage the central [....] » Read More

Speaker at Neuroscience Conference - Cesar Garcia-Cruz
Poster Presentation (In-Person)
Cesar Garcia-Cruz, Centro de Investigación y de Estudios Avanzados del IPN, Mexico

Dystrophin Dp40 is the shortest dystrophin described to date. Role of this protein in the cognitive impairment described in patients with Duchenne Muscular Dystrophy (DMD) is still unclear. Dp40 is expressed in a ubiquitous manner from the same promoter for dystrophin Dp71 (Tinsl [....] » Read More

Speaker at Brain Disorders Conference - Carlos Eduardo Monici Fernandes
Poster Presentation (In-Person)
Carlos Eduardo Monici Fernandes, Federal University, Brazil

Histamine H4 receptors agonist VUF-8430 have been shown participate in emotional memory. In the present study, the aim was to verify if the intraperitoneal (i.p.) injection of VUF-8430 (1.48 nmol; 10 ml / kg) in mice, acts on the protein synthesis required in memory consolidation [....] » Read More

Speaker at Neurology Conferences - Bruna Silva Marques
Poster Presentation (In-Person)
Bruna Silva Marques, Federal University of Sao Carlos, Brazil

The neural histaminergic system innervates the cerebellum, with high density of fibers in the vermis and flocculus. Experimental evidence indicates that cerebellum is involved in various non-motor as well as motor operations. However, the role of histaminergic system in these fun [....] » Read More

Speaker at Neuroscience Conference - Zofia Rogoz
Poster Presentation (In-Person)
Zofia Rogoz, Institute of Pharmacology Polish Academy of Sciences, Poland

Schizophrenia is a devastating psychiatric disorder that impairs mental and social functioning and affects approximately 1% of the world’s population. It is known that in contrast to pharmacotherapy with typical antipsychotics, atypical antipsychotic agents alleviate not on [....] » Read More

Speaker at Brain Disorders Conference - Kelly Regina Serafim
Poster Presentation (In-Person)
Kelly Regina Serafim, Center Universitary Central Paulista, Brazil

Pharmacological studies have demonstrated that histaminergic and nicotinic  cholinergic receptors modulate the mechanisms involved in the amygdala-dependent memory formation.  The aim of the present study was to investigate whether an agonist of the alpha 7 nicotinic ch [....] » Read More

Speaker at Neurology Conferences - Bartłomiej Stańczykiewicz
Poster Presentation (In-Person)
Bartłomiej Stańczykiewicz, Wroclaw Medical University, Poland

Cysteine proteases inhibitors play an important role in the neurodegenerative disorders. Cystatin isolated from chicken egg white, called ovocystatin has been widely used in pharmaceutical and medical research due to its structural and biological similarities to human cystatin C. [....] » Read More

Speaker at Brain Disorders Conference - Choon-Gon Jang
Poster Presentation (In-Person)
Choon-Gon Jang, Sungkyunkwan University, Korea, Republic of

It has been well known that lipopolysaccharide (LPS) induces neuroinflammation in rodents. However, anxiety- and depressive-like symptoms induced by LPS are known to be controversial. In the present study, we performed various mood disorder experiments such as open field test (OF [....] » Read More

Speaker at Neuroscience Conference - Howard. H. Fenn
Poster Presentation (In-Person)
Howard. H. Fenn, Stanford University, United States

Treatment of the geriatric patient on an inpatient unit is among the most complex challenges in clinical psychiatry. The patient is at the nexus of a number of problems, all interacting in ways that are often impossible to parse: aging, neurocognitive decline, non-cognitive sympt [....] » Read More

Speaker at Neurology Conferences - Keerthi Madhurya Kethireddi
Poster Presentation (In-Person)
Keerthi Madhurya Kethireddi, EastSussesx Healthcare NHS Trust, United Kingdom

Angiotrophic B cell lymphoma, also called as Intravascular Lymphoma is a rare extra nodal type of lymphoma. The Clinical symptoms of the disease depends on the organs involved. It often presented atypically and that makes timely and accurate diagnosis of angiocentric lymphomas ve [....] » Read More

Speaker at Brain Disorders Conference - Bernadete Marcia Voichcoski
Poster Presentation (In-Person)
Bernadete Marcia Voichcoski, Technological Federal University of Parana/Electronica, Brazil

The Schizophrenia Spectrum is a set of neuroencephalo abnormalities that occurs at different levels and can cause delusions, hallucinations, behavioral disorders and causes cognitive impairment. The initial diagnosis is not easy and the delay in treatment causes irreversible brai [....] » Read More

Speaker at Neuroscience Conference - Doa Pan
Poster Presentation (In-Person)
Doa Pan, CCHMC, United States

Primary brain microvessels (BrMV) maintain the cellular characters and molecular signatures as displayed in vivo, thus serve as a vital tool for biomedical research of the blood-brain barrier (BBB) and the development/optimization of brain drug delivery. The variations of relativ [....] » Read More

Speaker at Neurology Conferences - Anastassiya Perfilyeva
Poster Presentation (In-Person)
Anastassiya Perfilyeva, Institute of General Genetics and Cytology CS MES RK, Kazakhstan

Autism spectrum disorder (ASD) is a complex heterogeneous childhood neuropsychiatric disorders mainly characterized by deficits in verbal and non-verbal communication, reciprocal social interactions, and stereotyped behavior. Despite the increased worldwide interest of scientists [....] » Read More

Speaker at Brain Disorders Conference - DJansugurova Leila
Poster Presentation (In-Person)
DJansugurova Leila, Institute of General Genetics and Cytology CS MES RK, Kazakhstan

Epilepsy is one of the most common and heterogeneous neurological diseases. In Kazakhstan, more than 45,000 people suffer from epilepsy, 40% of them are children, adolescents and young people, 38% of patients become disabled, and their life quality reduces by 85% on average. The [....] » Read More

Speaker at Neuroscience Conference - Karine Bertoldi
Poster Presentation (In-Person)
Karine Bertoldi, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS,, Brazil

A neuroprotective function of adenosine against ischemic/excitotoxic cell damage has been demonstrated. The adenosine receptors named A1, A2A, A2B, and A3 have been implicated in a wide range of biological functions as well as in pathological states such as ischemic injury. [....] » Read More

Speaker at Neurology Conferences - Arjay Dannug
Poster Presentation (In-Person)
Arjay Dannug, Makati Medical Center, Philippines

Introduction: Parkinson’s disease (PD) and X-linked dystonia parkinsonism (XDP) cause dramatic disease burden to patient’s quality of life and even to the family members or caregivers. Symptoms eventually progress in time but is not necessarily equated to decline i [....] » Read More

Speaker at Brain Disorders Conference - Najib Murr
Keynote Presentation (In-Person)
Najib Murr, SIU Medecine, United States

This presentation will discuss the definition of NCSE, types, classifications, epidemiology and pathophysiology in addition to treatment and outcome. Will highlight the importance of early diagnosis. Uncommon presentations and EEG features.   This is not a research pres [....] » Read More

Speaker at Brain Disorders Conference - Viviane Rostirola Elsner
Keynote Presentation (In-Person)
Viviane Rostirola Elsner, IPA Methodist University, Brazil

Emerging evidences have been pointed out that the imbalance of epigenetic machinery exert a pivotal role in the physiopathology of several neurological, neurodegenerative and neuropsychiatric conditions. However, this relationship in spinal cord injury (SCI) have been poorly inve [....] » Read More

Speaker at  - Marat Akhmet
Keynote Presentation (In-Person)
Marat Akhmet, Middle East Technical University, Turkey

We will consider two subjects of nonlinear dynamics: synchronization of integrate-and-fire biological oscillators; global chaos in neural networks and discuss their importance for brain activity from the dynamical systems and information dynamics point of view. The collective beh [....] » Read More

Speaker at Neuroscience Conference - Hazem A. Mostafa
Keynote Presentation (In-Person)
Hazem A. Mostafa, Ain Shams University, Egypt

Craniofacial anomalies are rare complex pathologies which needs a craniofacial team composed of neurosurgeon, a craniofacial plastic surgeon, and an ophthalmologist. Anomalies at craniofacial region either due to developmental malformation of the brain (neural tube defects) or pr [....] » Read More

Speaker at Neurology Conferences - Lucia Carvelli
Oral Presentation (In-Person)
Lucia Carvelli, Florida Atlantic University, United States

Amphetamine (AMPH) is used as psychostimulant, appetite suppressant and to treat Attention Deficit Hyperactive Disorder (ADHD). Among other effects, AMPH has been shown to alter the function of proteins uniquely associated with the reward system, i.e. the dopamine trans [....] » Read More

Speaker at Brain Disorders Conference - Yu Liu
Oral Presentation (In-Person)
Yu Liu, Jinan University, China

20-Hydroxyeicosatetraenoic acid (20-HETE), a cytochrome P450 (CYP450) metabolite of arachidonic acid (AA), is one of the primary eicosanoids in most of microcirculatory beds. Studies have indicated that this compound has important physiological and pathological functions in the m [....] » Read More

Speaker at Neuroscience Conference - Maurizio Petrarca
Oral Presentation (In-Person)
Maurizio Petrarca, Bambino Gesu Childrens Hospital, Italy

The focus of the presentation will be the use of technological tools for the assessment and the rehabilitation of children with neurological disorders. A brief historical introduction will be produced. Specific tools for the multi-factorial analysis of the movement have been deve [....] » Read More

Speaker at Neurology Conferences - Patrice Ntenga
Oral Presentation (In-Person)
Patrice Ntenga, Neurological Clinic of the National Teaching Hospital, Senegal

Motor impairment of cerebral origin is a syndrome that induces a reduction in activity, the origin of which is brain injury or a non-progressive and definitive abnormality occurring in a developing immature brain. Motor disability, spastic,  dyskinetic  or  ataxic, [....] » Read More

Speaker at Brain Disorders Conference - LORENA RUBIO
Oral Presentation (In-Person)
LORENA RUBIO, Institute of Neurobiology, Universidad Nacional Autonoma de Mexico, Mexico

The brain nucleus involve in learning flavors and food preferences appear early in life and continue through adulthood. Epigenetic factors like undernutrition can alter the brain process involved in food preferences. In the other hand, undernutrition is a public health problem of [....] » Read More

Watsapp